Integra LifeSciences Holdings Corporation Introduces Allograft Cancellous Sponge

PLAINSBORO, N.J., Feb. 7, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) announced today the launch of Integra™ Allograft Cancellous Sponge, a compressible bone graft composed of 100% cancellous bone. The sponge-like handling characteristics of Integra™ Allograft Cancellous Sponge allow it to absorb fluids like saline, blood or bone marrow aspirate. After rehydration, Integra™ Allograft Cancellous Sponge can be compressed to half its original size, and expands back to conform to a variety of spaces and defects, for maximum surgical flexibility.

MORE ON THIS TOPIC